From: The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
Variable | Log of plasma LL-37 (ng/ml) | Log of urine LL-37 ng/mg creatinine | ||||
---|---|---|---|---|---|---|
Coefficient | SE | P | Coefficient | SE | P | |
Age | −0.002 | 0.001 | 0.113 | 0.000 | 0.002 | 0.986 |
Male gender | −0.093 | 0.040 | 0.022 | −0.109 | 0.059 | 0.066 |
TWBCs | 0.018 | 0.008 | 0.038 | −0.012 | 0.013 | 0.358 |
Neutrophils | −0.001 | 0.006 | 0.893 | −0.001 | 0.007 | 0.913 |
Lymphocytes | −0.001 | 0.006 | 0.812 | −0.004 | 0.007 | 0.596 |
Basophiles | 0.001 | 0.008 | 0.933 | −0.007 | 0.010 | 0.513 |
Urinary tract infections | 0.153 | 0.045 | 0.001 | 0.162 | 0.077 | 0.038 |
Plasma LL-37 ng/ml | – | – | – | 0.238 | 0.019 | < 0.001 |